DOPAMINE-RECEPTORS IN THE BASAL GANGLIA - RELEVANCE TO PARKINSONS-DISEASE

被引:70
作者
STRANGE, PG
机构
[1] Biological Laboratory, The University, Canterbury, Kent
关键词
DOPAMINE RECEPTORS; PARKINSONS DISEASE; DRUG TREATMENT; NEOSTRIATUM; MOTOR CONTROL;
D O I
10.1002/mds.870080303
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
At least five receptors for dopamine (D1-D5) have been recognised from molecular biological studies, and their pharmacological properties and brain localisations have been determined. The D1 and D2 subtypes are the principal subtypes in brain, and their cellular localisations in the caudate nucleus and putamen have been determined. With recent advances in the understanding of basal ganglia neuronal function, these localisation data enable insights into the mode of action of drugs used at present and in the future to treat Parkinson's disease.
引用
收藏
页码:263 / 270
页数:8
相关论文
共 55 条
[1]   THE FUNCTIONAL-ANATOMY OF BASAL GANGLIA DISORDERS [J].
ALBIN, RL ;
YOUNG, AB ;
PENNEY, JB .
TRENDS IN NEUROSCIENCES, 1989, 12 (10) :366-375
[2]  
ALEXANDER GE, 1990, PROG BRAIN RES, V85, P119
[3]   PARALLEL ORGANIZATION OF FUNCTIONALLY SEGREGATED CIRCUITS LINKING BASAL GANGLIA AND CORTEX [J].
ALEXANDER, GE ;
DELONG, MR ;
STRICK, PL .
ANNUAL REVIEW OF NEUROSCIENCE, 1986, 9 :357-381
[4]   HOMOLOGOUS DESENSITIZATION OF THE D1 DOPAMINE RECEPTOR [J].
BALMFORTH, AJ ;
WARBURTON, P ;
BALL, SG .
JOURNAL OF NEUROCHEMISTRY, 1990, 55 (06) :2111-2116
[5]  
BARTON AC, 1990, MOL PHARMACOL, V38, P531
[6]  
BARTON AC, 1991, MOL PHARMACOL, V39, P650
[7]   LOCALIZATION OF DOPAMINE-D3 RECEPTOR MESSENGER-RNA IN THE RAT-BRAIN USING INSITU HYBRIDIZATION HISTOCHEMISTRY - COMPARISON WITH DOPAMINE-D2 RECEPTOR MESSENGER-RNA [J].
BOUTHENET, ML ;
SOUIL, E ;
MARTRES, MP ;
SOKOLOFF, P ;
GIROS, B ;
SCHWARTZ, JC .
BRAIN RESEARCH, 1991, 564 (02) :203-219
[8]   DIFFERENTIAL-EFFECTS OF D1 AND D2 AGONISTS IN MPTP-TREATED PRIMATES - FUNCTIONAL IMPLICATIONS FOR PARKINSONS-DISEASE [J].
BOYCE, S ;
RUPNIAK, NMJ ;
STEVENTON, MJ ;
IVERSEN, SD .
NEUROLOGY, 1990, 40 (06) :927-933
[9]   SELECTIVE D-1 DOPAMINE RECEPTOR AGONIST TREATMENT OF PARKINSONS-DISEASE [J].
BRAUN, A ;
FABBRINI, G ;
MOURADIAN, MM ;
SERRATI, C ;
BARONE, P ;
CHASE, TN .
JOURNAL OF NEURAL TRANSMISSION, 1987, 68 (1-2) :41-50
[10]   DIFFERENCES IN THE LIGAND-BINDING PROPERTIES OF THE SHORT AND LONG VERSIONS OF THE D2 DOPAMINE RECEPTOR [J].
CASTRO, SW ;
STRANGE, PG .
JOURNAL OF NEUROCHEMISTRY, 1993, 60 (01) :372-375